Current role of trisectionectomy for hepatopancreatobiliary malignancies.
Philipp KronNorihisa KimuraShahid FaridJ Peter A LodgePublished in: Annals of gastroenterological surgery (2019)
With the further development of surgical and multimodal treatment strategies in CRLM the indications for trisectionectomy are decreasing. Having being formerly associated with high rates of perioperative morbidity and mortality, this single-center experience clearly shows that these concomitant risks decrease with experience, liberal use of portal vein embolization and improved patient selection. Trisectionectomy remains relevant in selected patients.